Access Guides

Reserve Meds is a digital health company. We help patients outside the US, and their doctors, access FDA-approved US medicines through legal named-patient import routes. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. Each guide explains, for one medicine and one country, the access route, who applies and which documents are needed.

Country-specific pathway guides for named-patient import.

This library collects 3,076 country-specific access guides covering specialty and rare-disease medicines across 25 countries. Each guide walks a treating physician and a patient family through the legal named-patient import pathway in a specific destination: the clinical situation, whether the drug is lawfully importable, the step-by-step application, what documentation is required, typical timing and how quotes work, and where Reserve Meds fits as a sourcing and coordination partner.

Timelines are estimates, not guarantees. We give you a written timeline estimate for your case before you commit. If your case is time-sensitive, tell us when you contact us.

Arabic drafts for 40 paired guides are available at /ar/access-guides/.

Access Guides

Drug overview hubs (no country) (65)

Bahrain (277)

Bangladesh (87)

Egypt (201)

India (247)

Iraq (30)

Jordan (111)

Kuwait (276)

Lebanon (58)

Morocco (31)

Nepal (76)

Nigeria (1)

Oman (233)

Pakistan (185)

Philippines (30)

Qatar (271)

Saudi Arabia (341)

South Africa (30)

Sri Lanka (61)

Thailand (30)

Turkey (90)

United Arab Emirates (330)

United Kingdom (15)

More country guides

Priority guides

Duchenne muscular dystrophy

Recently FDA-approved

Saudi Arabia and UAE guides